3ml High Purity Safe Delivery China Most Professional Factory Supply High Qulity ISU
TDS 1 Inquiries
116094-23-6
Pharmaceutical Grade
99.9%
shanghai
shuyou
10vials
2026-03-31
Peptides,steriods oil,pharmaceutical intermediates,chemical,raw powder,Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
3ml High Purity Safe Delivery China Most Professional Factory Supply High Qulity ISU is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
CertificatesBasic Info-
Product Name:
INSULIN ASPART
Other Name:INSULIN ASPART;D04475;Insulin aspart (genetical recombination);Insulin aspart (genetical recombination) (jan);Insulin aspart (usan/inn);Insulin X 14;Novolog;Novolog (tn)
CAS No.:116094-23-6
Molecular Formula:C256H381N65O79S6
Categories:
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Peptides,steriods oil,pharmaceutical intermediates,chemical,raw powder,Retatrutide
-
Location:
15b3-1, Building 3, China Plastic City International Business Center, No. 285 Shunda West Road, Yangming Street, Ningbo, Zhejiang, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2024
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Philippines
Insulin aspart
1 MG Dec 2, 2025 Post an enquiry for this product
